Abstract
We have not added the abstract for this paper yet. The publisher's page has the full record.
Safety and efficacy of edonerpic maleate for patients with mild to moderate Alzheimer disease: a phase 2 randomized clinical trial
JAMA neurology · Vol. 76, pp. 1330-1339 Published January 1, 2019
More on these topics
Browse all publications →-
2026 · Nat Med
Target product profiles for treatments to delay or prevent symptomatic Alzheimer's disease
-
2025 · Neurotherapeutics
Evaluation of exploratory fluid biomarkers from a phase 1 senolytic trial in mild Alzheimer's disease
-
2025 · J Prev Alzheimers Dis
Donanemab: Appropriate use recommendations
-
2024 · Alzheimer's Association International Conference (AAIC)
Navigating the Complexities of Alzheimer's Clinical Trials: The Perils of Small Molecule Studies and the Risk of Fraudulent Practices